News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Toby Eyre: Big news in CLL
Toby Eyre/X
Dec 5, 2023, 12:57

Toby Eyre: Big news in CLL

Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter:

“Big news in CLL. Pirtobrutinib now FDA-approved in patients who have received a prior cov BTKi and BCL2i following results of the BRUIN trial. Jaypirca (pirtobrutinib) now Approved by U.S. FDA for the Treatment of Adult Patients with CLL.”

For the article click here.
Source: Toby Eyre/X

bcl-2 inhibitor BRUIN trial BTK inhibitor cancer CLL FDA approval Jaypirca OncoDaily Oncology Oxford University Hospitals Pirtobrutinib Toby Eyre
Special Coverage
Blog
Mar 26, 2025, 16:17
We are proud to announce the renewal of our partnership with the IAEA - City Cancer Challenge
Blog
Mar 26, 2025, 15:47
ESMO has just announced the ESMO Ambassadors for this year’s ELCC - LuCE
Blog
Mar 26, 2025, 15:14
Jessie Yu: Excited for the upcoming BIOCHINA Global Forum in Seoul on September 12th
Blog
Mar 26, 2025, 15:07
1 month left to submit your abstract for SIOG 2025
Blog
Mar 26, 2025, 14:53
Pashtoon Kasi: Different lenses of looking at the same biology
Blog
Mar 26, 2025, 14:43
Tuan Thanh Nguyen: Global survey on disparities in Prostate Cancer care
Science
Mar 26, 2025, 14:35
Oscar Tahuahua: If quitting smoking gave you back 10 yrs, would you believe it?
Blog
Mar 26, 2025, 14:29
Sunil Verma: It was wonderful to visit India and our AstraZeneca India teams there
Science
Mar 26, 2025, 14:26
Yüksel Ürün: Revolution in Metastatic Melanoma
Blog
Mar 26, 2025, 14:18
David Planchard: Take home messages by Fabrice Barlesi on oncogenic treatment of localised NSCLC in 2025
Blog
Mar 26, 2025, 14:11
ECOG-ACRIN Cancer Research Group is now enrolling for EAQ222CD/CostCOM
Science
Mar 26, 2025, 14:03
Nita Radhakrishnan: Cost analysis of thalassemia screening vs treatment in different health care sectors